HSD17B3

UniProt ID: P37058
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

Testis-specific 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-HSD3), a member of the short-chain dehydrogenase/reductase (SDR) superfamily. It is an NADPH-dependent oxidoreductase anchored in the endoplasmic reticulum membrane that catalyses the final step of testosterone biosynthesis: reduction of the 17-keto group of androstenedione (androst-4-ene-3,17-dione) to the 17beta-hydroxyl, yielding testosterone. It reduces additional 17-ketosteroids (e.g. dehydroepiandrosterone, epiandrosterone, androstanedione, and 11-oxygenated C19 steroids), and can also interconvert estrone and 17beta-estradiol. Expressed predominantly in the testis, where it supplies the androgen needed for masculinization. Loss-of-function mutations cause an autosomal-recessive 46,XY disorder of sex development (17beta-HSD3 deficiency; male pseudohermaphroditism with gynecomastia), in which affected 46,XY individuals are undervirilized and show a characteristically decreased plasma testosterone-to-androstenedione ratio.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005783 endoplasmic reticulum
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) localization to the endoplasmic reticulum. HSD17B3 is an ER-membrane-anchored SDR enzyme; direct human experimental data and Reactome agree, so this is accurate.
Reason: Consistent with the experimentally determined ER localization of the human enzyme and its N-terminal membrane anchor. A more specific ER membrane term exists (see GO:0005789) but the parent ER term is correct.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum
GO:0047045 testosterone dehydrogenase (NADP+) activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) assignment of the core catalytic function: NADP-dependent testosterone 17beta-dehydrogenase activity (testosterone + NADP+ <-> androstenedione + NADPH), the physiological direction being reduction of androstenedione to testosterone.
Reason: This is the defining molecular function of HSD17B3, supported by direct human enzymology. The IBA agrees with IDA and TAS annotations of the same term.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
testosterone + NADP(+) = androst-4-ene-3,17-dione + NADPH
PMID:8075637
uses NADPh as a cofactor, and
GO:0006694 steroid biosynthetic process
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) assignment to steroid biosynthesis. HSD17B3 acts in androgen/testosterone biosynthesis, which is a steroid biosynthetic process.
Reason: Correct but general. The more specific androgen/testosterone biosynthetic process terms (GO:0006702, GO:0061370) better capture the role; this parent term is retained as accurate context.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
Hormone biosynthesis; testosterone biosynthesis.
GO:0004303 estradiol 17-beta-dehydrogenase [NAD(P)+] activity
IEA
GO_REF:0000120
KEEP AS NON CORE
Summary: IEA (EC 1.1.1.62 / Rhea) mapping to estradiol 17-beta-dehydrogenase activity. HSD17B3 can catalyse the 17beta-estradiol <-> estrone interconversion, so the activity is real, but it is a minor/secondary activity, not the physiological role of this testicular androgenic enzyme.
Reason: The 17beta-estradiol + NADP+ = estrone + NADPH reaction (RHEA:24616, EC 1.1.1.62) is documented for the enzyme in UniProt, justifying the mapping, but the physiologically important, testis-relevant activity is testosterone dehydrogenase (androstenedione->testosterone). Retain as non-core.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
17beta-estradiol + NADP(+) = estrone + NADPH + H(+);
GO:0005783 endoplasmic reticulum
IEA
GO_REF:0000120
ACCEPT
Summary: IEA (UniProt SubCell / ARBA) localization to the endoplasmic reticulum, duplicating the IBA/IDA ER annotations. Correct.
Reason: Matches the experimentally determined ER localization of the human enzyme.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum
GO:0008610 lipid biosynthetic process
IEA
GO_REF:0000117
MARK AS OVER ANNOTATED
Summary: IEA (ARBA) mapping to lipid biosynthetic process. Steroids are technically lipids, so this is not strictly wrong, but it is far too general and uninformative for a testosterone-biosynthetic enzyme.
Reason: The specific role of HSD17B3 is in androgen/testosterone (steroid hormone) biosynthesis, already captured by GO:0006702 and GO:0061370. The generic lipid biosynthetic process term over-generalizes and adds no useful signal.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
Hormone biosynthesis; testosterone biosynthesis.
GO:0016614 oxidoreductase activity, acting on CH-OH group of donors
IEA
GO_REF:0000117
ACCEPT
Summary: IEA (ARBA) mapping to the general oxidoreductase activity acting on CH-OH group of donors. HSD17B3 is a hydroxysteroid dehydrogenase (reduces 17-keto to 17beta-hydroxy using NADPH), so this parent term is correct.
Reason: Accurate but general parent of the specific 17beta-HSD / testosterone dehydrogenase activity. Retained as correct context.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
Uses NADPH
GO:0047045 testosterone dehydrogenase (NADP+) activity
IEA
GO_REF:0000120
ACCEPT
Summary: IEA (EC 1.1.1.64 / Rhea RHEA:14981) mapping to testosterone dehydrogenase (NADP+) activity, duplicating the core IBA/IDA/TAS molecular-function annotation.
Reason: Core catalytic function, independently supported by direct human enzymology and by the EC/Rhea mapping (testosterone + NADP+ = androstenedione + NADPH).
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
testosterone + NADP(+) = androst-4-ene-3,17-dione + NADPH
GO:0072582 17-beta-hydroxysteroid dehydrogenase (NADP+) activity
IEA
GO_REF:0000116
ACCEPT
Summary: IEA (Rhea) mapping to 17-beta-hydroxysteroid dehydrogenase (NADP+) activity, the general reaction (a 17beta-hydroxy steroid + NADP+ = a 17-oxo steroid + NADPH). This is the family-level activity that HSD17B3 carries out on multiple 17-ketosteroid substrates.
Reason: Accurately describes the enzyme's broad 17beta-HSD activity across several 17-oxosteroid substrates (androstenedione, DHEA, androstanedione, 11-oxygenated C19 steroids), reducing them at C-17 using NADPH. Complements the more specific testosterone dehydrogenase term.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
Favors the reduction of
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding annotation from a high-throughput affinity-purification mass-spectrometry human interactome map (BioPlex), with interactor NCS1 (UniProtKB:P62166).
Reason: Bare "protein binding" from a proteome-scale interactome screen is uninformative about the molecular function of HSD17B3 and does not represent a characterized, biologically interpreted interaction. Per curation guidelines, such generic protein-binding terms should not be treated as core function.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
P37058; P62166: NCS1;
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding annotation from a second proteome-scale AP-MS human interactome study (BioPlex 3.0), again with interactor NCS1 (UniProtKB:P62166).
Reason: As with the companion interactome dataset, this generic "protein binding" annotation from a high-throughput screen is uninformative for molecular function and is not core.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
P37058; P62166: NCS1;
GO:0006702 androgen biosynthetic process
TAS
Reactome:R-HSA-193048
ACCEPT
Summary: TAS (Reactome, Androgen biosynthesis) assignment to androgen biosynthetic process. HSD17B3 catalyses the terminal androstenedione->testosterone step of androgen (testosterone) biosynthesis.
Reason: Testosterone is an androgen and HSD17B3 performs the final reductive step of its synthesis, so this is a correct and central biological-process annotation.
Supporting Evidence:
PMID:8075637
Defects in the conversion of androstenedione to testosterone in the fetal testes
GO:0061370 testosterone biosynthetic process
IEA
GO_REF:0000041
ACCEPT
Summary: IEA (UniPathway UPA00367) assignment to testosterone biosynthetic process, the most specific biological process for this enzyme's role.
Reason: HSD17B3 catalyses the final, committed step producing testosterone; UniProt records the pathway "Hormone biosynthesis; testosterone biosynthesis". This is the most precise BP term and represents a core function.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
Hormone biosynthesis; testosterone biosynthesis.
GO:0047045 testosterone dehydrogenase (NADP+) activity
TAS
Reactome:R-HSA-193064
ACCEPT
Summary: TAS (Reactome, HSD17B3-like proteins reduce ANDST to TEST) assignment of testosterone dehydrogenase (NADP+) activity, duplicating the core molecular function.
Reason: Core catalytic function; consistent with the IBA/IDA/IEA annotations of the same term and with the reduction of androstenedione to testosterone.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
testosterone + NADP(+) = androst-4-ene-3,17-dione + NADPH
GO:0005783 endoplasmic reticulum
IDA
PMID:26545797
Biochemical analyses and molecular modeling explain the func...
ACCEPT
Summary: IDA localization to the endoplasmic reticulum. Engeli et al. expressed wild-type 17beta-HSD3 (and the G133R mutant) in HEK-293 cells and assessed intracellular localization; both showed comparable ER localization.
Reason: Direct experimental evidence for ER localization of the human enzyme in a cellular expression system, consistent with its membrane anchor.
Supporting Evidence:
PMID:26545797
showed comparable expression levels and intracellular localization.
GO:0047045 testosterone dehydrogenase (NADP+) activity
IDA
PMID:26545797
Biochemical analyses and molecular modeling explain the func...
ACCEPT
Summary: IDA for testosterone dehydrogenase (NADP+) activity. Engeli et al. measured the conversion of androstenedione to testosterone by wild-type 17beta-HSD3 (nearly abolished in the disease mutant G133R), directly demonstrating the enzyme activity.
Reason: Direct assay of the enzyme's testosterone-producing 17beta-reductase activity in a human expression system; the defining core molecular function.
Supporting Evidence:
PMID:26545797
conversion of Δ4-androstene-3,17-dione (androstenedione) to testosterone was
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-193064
ACCEPT
Summary: TAS (Reactome) localization to the endoplasmic reticulum membrane, the most precise cellular-component term. HSD17B3 has an N-terminal hydrophobic segment that anchors it in the ER membrane.
Reason: Most specific and accurate location for this membrane-anchored ER enzyme; preferred over the parent GO:0005783 term.
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum
GO:0030539 male genitalia development
TAS
PMID:8075637
Male pseudohermaphroditism caused by mutations of testicular...
KEEP AS NON CORE
Summary: TAS (Geissler et al. 1994) involvement in male genitalia development. Deficiency of 17beta-HSD3 impairs fetal testicular testosterone synthesis, giving 46,XY individuals female external genitalia (male pseudohermaphroditism).
Reason: This is a real but downstream physiological/developmental consequence of the enzyme's biochemical activity (testosterone drives male sexual differentiation), not the molecular/biosynthetic core function. Retained as non-core to preserve the well-established disease/developmental link.
Supporting Evidence:
PMID:8075637
Defects in the conversion of androstenedione to testosterone in the fetal testes
file:human/HSD17B3/HSD17B3-uniprot.txt
inadequate testicular synthesis of
GO:0043231 intracellular membrane-bounded organelle
TAS
PMID:8075637
Male pseudohermaphroditism caused by mutations of testicular...
MODIFY
Summary: TAS (Geissler et al. 1994) localization to an intracellular membrane-bounded organelle. The original paper described the enzyme as microsomal (ER); the annotation is correct but far more general than the known ER localization.
Reason: The enzyme is specifically an ER (microsomal) membrane protein, established by direct experimental evidence. This generic organelle term should be replaced with the specific endoplasmic reticulum term.
Proposed replacements: endoplasmic reticulum
Supporting Evidence:
file:human/HSD17B3/HSD17B3-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum

Core Functions

NADPH-dependent 17beta-hydroxysteroid (testosterone) dehydrogenase that catalyses the final step of testosterone biosynthesis in the testis, reducing the 17-keto group of androstenedione to give testosterone at the endoplasmic reticulum membrane.

Supporting Evidence:
  • file:human/HSD17B3/HSD17B3-uniprot.txt
    testosterone + NADP(+) = androst-4-ene-3,17-dione + NADPH
  • PMID:26545797
    conversion of Δ4-androstene-3,17-dione (androstenedione) to testosterone was

References

Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniPathway vocabulary mapping
Automatic Gene Ontology annotation based on Rhea mapping
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
file:human/HSD17B3/HSD17B3-uniprot.txt
UniProtKB entry P37058 (DHB3_HUMAN), 17-beta-hydroxysteroid dehydrogenase type 3
Biochemical analyses and molecular modeling explain the functional loss of 17β-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with 46, XY Disorders of Sex Development.
Architecture of the human interactome defines protein communities and disease networks.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3.
Reactome:R-HSA-193048
Androgen biosynthesis
Reactome:R-HSA-193064
HSD17B3-like proteins reducde ANDST to TEST

📚 Additional Documentation

Notes

(HSD17B3-notes.md)

HSD17B3 (P37058) review notes

Identity / summary

  • 17-beta-hydroxysteroid dehydrogenase type 3 (17β-HSD3); testicular isozyme; SDR family (12C2 / SDR12C2).
  • Testis-specific NADPH-dependent oxidoreductase, ER-membrane bound, that catalyses the final step of testosterone biosynthesis: reduction of the 17-keto group of androstenedione (Δ4-androstene-3,17-dione) to the 17β-hydroxyl giving testosterone. Also reduces other 17-ketosteroids (DHEA, epiandrosterone, androstanedione, 11-oxygenated C19 steroids).
  • Deficiency causes 46,XY disorder of sex development (17β-HSD3 deficiency / male pseudohermaphroditism with gynecomastia, MIM:264300): undervirilized 46,XY individuals; diagnostic hallmark is a decreased testosterone-to-androstenedione ratio.

Key provenance (from UniProt P37058 + cached PMIDs)

  • UniProt FUNCTION: "Catalyzes the conversion of 17-oxosteroids to 17beta-hydroxysteroids ... Favors the reduction of androstenedione to testosterone ... Uses NADPH while the two other EDH17B enzymes use NADH." (PubMed:16216911, 23856005, 26545797, 27927697, 8075637). [file:human/HSD17B3/HSD17B3-uniprot.txt]
  • Catalytic activity: testosterone + NADP+ = androst-4-ene-3,17-dione + NADPH + H+ (RHEA:14981, EC 1.1.1.64), physiological direction right-to-left (i.e. androstenedione -> testosterone). [file:human/HSD17B3/HSD17B3-uniprot.txt]
  • Also: 17β-estradiol + NADP+ = estrone + NADPH + H+ (RHEA:24616, EC 1.1.1.62) - the estradiol 17β-dehydrogenase activity underlying the IEA EC mapping. [file:human/HSD17B3/HSD17B3-uniprot.txt]
  • SUBCELLULAR LOCATION: Endoplasmic reticulum (PubMed:16216911, 26545797). ER membrane per Reactome. N-terminal hydrophobic segment anchors to ER membrane. [file:human/HSD17B3/HSD17B3-uniprot.txt]
  • TISSUE SPECIFICITY: Testis (PubMed:8075637). [file:human/HSD17B3/HSD17B3-uniprot.txt]
  • PATHWAY: Hormone biosynthesis; testosterone biosynthesis. Steroid metabolism. [file:human/HSD17B3/HSD17B3-uniprot.txt]
  • SIMILARITY: short-chain dehydrogenases/reductases (SDR) family, 17-beta-HSD 3 subfamily. Rossmann fold NAD(P)-binding; ACT_SITE Tyr198; NADP binding 48-77. [file:human/HSD17B3/HSD17B3-uniprot.txt]
  • DISEASE (MPH / 46,XY DSD): "inadequate testicular synthesis of testosterone ... a diagnostic hallmark of this disorder is a decreased plasma testosterone-to-androstenedione ratio." [file:human/HSD17B3/HSD17B3-uniprot.txt]

Cached publications

  • PMID:8075637 (Geissler 1994, Nat Genet) abstract-only. Isolated cDNA encoding "a microsomal 17 beta-HSD type 3 isozyme ... uses NADPh as a cofactor, and is expressed predominantly in the testes"; mutations cause male pseudohermaphroditism via defective androstenedione->testosterone conversion "in the fetal testes". Basis for MF (testosterone 17β-DH), tissue (testis), disease, and male genitalia development annotations.
  • PMID:26545797 (Engeli 2016, JSBMB) abstract-only. G133R mutant: "conversion of Δ4-androstene-3,17-dione (androstenedione) to testosterone was almost completely abolished for mutant G133R compared with wild-type 17β-HSD3"; "Wild-type 17β-HSD3 and mutant G133R showed comparable expression levels and intracellular localization." Supports MF (androstenedione->testosterone reduction) and ER localization (IDA). NADPH cofactor pocket residue G133.
  • PMID:28514442 (Huttlin 2017, BioPlex/interactome) and PMID:33961781 (Huttlin 2021) - high-throughput AP-MS interactome papers; IntAct IPI protein-binding annotations (interactor P62166 = NCS1). Not informative MF; over-annotation.

Annotation decisions (summary)

  • MF testosterone dehydrogenase (NADP+) activity GO:0047045 (IBA, IDA, TAS): ACCEPT - core catalytic function.
  • MF 17-beta-hydroxysteroid dehydrogenase (NADP+) activity GO:0072582 (IEA/RHEA): ACCEPT - accurate general MF for the reaction family (matches Rhea reactions incl. RHEA:69284 the generic 17β-OH steroid + NADP reaction). Broader-but-correct.
  • MF estradiol 17-beta-dehydrogenase [NAD(P)+] activity GO:0004303 (IEA EC 1.1.1.62): KEEP_AS_NON_CORE - real minor activity (estradiol<->estrone) documented in UniProt, but not the physiological role; keep, non-core.
  • MF oxidoreductase activity, acting on CH-OH group of donors GO:0016614 (IEA ARBA): ACCEPT (parent) - correct but general.
  • MF protein binding GO:0005515 x2 (IPI, NCS1): MARK_AS_OVER_ANNOTATED - uninformative bare protein binding from HT interactome screens.
  • BP androgen biosynthetic process GO:0006702 (TAS Reactome): ACCEPT - core process (testosterone is an androgen; final step).
  • BP testosterone biosynthetic process GO:0061370 (IEA UniPathway): ACCEPT - core, most specific BP.
  • BP steroid biosynthetic process GO:0006694 (IBA): ACCEPT (parent) - correct but general.
  • BP lipid biosynthetic process GO:0008610 (IEA ARBA): MARK_AS_OVER_ANNOTATED - technically steroids are lipids but far too general/uninformative for this enzyme.
  • BP male genitalia development GO:0030539 (TAS PMID:8075637): KEEP_AS_NON_CORE - downstream physiological consequence (testosterone drives male development); not the molecular/biosynthetic core.
  • CC endoplasmic reticulum GO:0005783 (IBA, IEA, IDA): ACCEPT.
  • CC endoplasmic reticulum membrane GO:0005789 (TAS Reactome): ACCEPT - most specific/correct (membrane-anchored ER protein).
  • CC intracellular membrane-bounded organelle GO:0043231 (TAS PMID:8075637): MODIFY -> ER (GO:0005783); overly general given known ER localization.

Core functions

  • MF GO:0047045 testosterone dehydrogenase (NADP+) activity; directly_involved_in GO:0006702 androgen biosynthetic process (+ GO:0061370 testosterone biosynthetic process); located_in GO:0005789 endoplasmic reticulum membrane.

📄 View Raw YAML

id: P37058
gene_symbol: HSD17B3
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  Testis-specific 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-HSD3), a
  member of the short-chain dehydrogenase/reductase (SDR) superfamily. It is an
  NADPH-dependent oxidoreductase anchored in the endoplasmic reticulum membrane
  that catalyses the final step of testosterone biosynthesis: reduction of the
  17-keto group of androstenedione (androst-4-ene-3,17-dione) to the 17beta-hydroxyl,
  yielding testosterone. It reduces additional 17-ketosteroids (e.g.
  dehydroepiandrosterone, epiandrosterone, androstanedione, and 11-oxygenated C19
  steroids), and can also interconvert estrone and 17beta-estradiol. Expressed
  predominantly in the testis, where it supplies the androgen needed for
  masculinization. Loss-of-function mutations cause an autosomal-recessive 46,XY
  disorder of sex development (17beta-HSD3 deficiency; male pseudohermaphroditism
  with gynecomastia), in which affected 46,XY individuals are undervirilized and
  show a characteristically decreased plasma testosterone-to-androstenedione ratio.
alternative_products:
- name: '1'
  id: P37058-1
- name: '2'
  id: P37058-2
  sequence_note: VSP_056640
existing_annotations:
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Phylogenetic (IBA) localization to the endoplasmic reticulum. HSD17B3 is an
      ER-membrane-anchored SDR enzyme; direct human experimental data and Reactome
      agree, so this is accurate.
    action: ACCEPT
    reason: >-
      Consistent with the experimentally determined ER localization of the human
      enzyme and its N-terminal membrane anchor. A more specific ER membrane term
      exists (see GO:0005789) but the parent ER term is correct.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Endoplasmic reticulum"
- term:
    id: GO:0047045
    label: testosterone dehydrogenase (NADP+) activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Phylogenetic (IBA) assignment of the core catalytic function: NADP-dependent
      testosterone 17beta-dehydrogenase activity (testosterone + NADP+ <->
      androstenedione + NADPH), the physiological direction being reduction of
      androstenedione to testosterone.
    action: ACCEPT
    reason: >-
      This is the defining molecular function of HSD17B3, supported by direct human
      enzymology. The IBA agrees with IDA and TAS annotations of the same term.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "testosterone + NADP(+) = androst-4-ene-3,17-dione + NADPH"
    - reference_id: PMID:8075637
      supporting_text: "uses NADPh as a cofactor, and"
- term:
    id: GO:0006694
    label: steroid biosynthetic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetic (IBA) assignment to steroid biosynthesis. HSD17B3 acts in
      androgen/testosterone biosynthesis, which is a steroid biosynthetic process.
    action: ACCEPT
    reason: >-
      Correct but general. The more specific androgen/testosterone biosynthetic
      process terms (GO:0006702, GO:0061370) better capture the role; this parent
      term is retained as accurate context.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "Hormone biosynthesis; testosterone biosynthesis."
- term:
    id: GO:0004303
    label: estradiol 17-beta-dehydrogenase [NAD(P)+] activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      IEA (EC 1.1.1.62 / Rhea) mapping to estradiol 17-beta-dehydrogenase activity.
      HSD17B3 can catalyse the 17beta-estradiol <-> estrone interconversion, so the
      activity is real, but it is a minor/secondary activity, not the physiological
      role of this testicular androgenic enzyme.
    action: KEEP_AS_NON_CORE
    reason: >-
      The 17beta-estradiol + NADP+ = estrone + NADPH reaction (RHEA:24616, EC
      1.1.1.62) is documented for the enzyme in UniProt, justifying the mapping, but
      the physiologically important, testis-relevant activity is testosterone
      dehydrogenase (androstenedione->testosterone). Retain as non-core.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "17beta-estradiol + NADP(+) = estrone + NADPH + H(+);"
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: >-
      IEA (UniProt SubCell / ARBA) localization to the endoplasmic reticulum,
      duplicating the IBA/IDA ER annotations. Correct.
    action: ACCEPT
    reason: >-
      Matches the experimentally determined ER localization of the human enzyme.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Endoplasmic reticulum"
- term:
    id: GO:0008610
    label: lipid biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  qualifier: involved_in
  review:
    summary: >-
      IEA (ARBA) mapping to lipid biosynthetic process. Steroids are technically
      lipids, so this is not strictly wrong, but it is far too general and
      uninformative for a testosterone-biosynthetic enzyme.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The specific role of HSD17B3 is in androgen/testosterone (steroid hormone)
      biosynthesis, already captured by GO:0006702 and GO:0061370. The generic
      lipid biosynthetic process term over-generalizes and adds no useful signal.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "Hormone biosynthesis; testosterone biosynthesis."
- term:
    id: GO:0016614
    label: oxidoreductase activity, acting on CH-OH group of donors
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  qualifier: enables
  review:
    summary: >-
      IEA (ARBA) mapping to the general oxidoreductase activity acting on CH-OH
      group of donors. HSD17B3 is a hydroxysteroid dehydrogenase (reduces 17-keto
      to 17beta-hydroxy using NADPH), so this parent term is correct.
    action: ACCEPT
    reason: >-
      Accurate but general parent of the specific 17beta-HSD / testosterone
      dehydrogenase activity. Retained as correct context.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "Uses NADPH"
- term:
    id: GO:0047045
    label: testosterone dehydrogenase (NADP+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      IEA (EC 1.1.1.64 / Rhea RHEA:14981) mapping to testosterone dehydrogenase
      (NADP+) activity, duplicating the core IBA/IDA/TAS molecular-function
      annotation.
    action: ACCEPT
    reason: >-
      Core catalytic function, independently supported by direct human enzymology
      and by the EC/Rhea mapping (testosterone + NADP+ = androstenedione + NADPH).
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "testosterone + NADP(+) = androst-4-ene-3,17-dione + NADPH"
- term:
    id: GO:0072582
    label: 17-beta-hydroxysteroid dehydrogenase (NADP+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      IEA (Rhea) mapping to 17-beta-hydroxysteroid dehydrogenase (NADP+) activity,
      the general reaction (a 17beta-hydroxy steroid + NADP+ = a 17-oxo steroid +
      NADPH). This is the family-level activity that HSD17B3 carries out on multiple
      17-ketosteroid substrates.
    action: ACCEPT
    reason: >-
      Accurately describes the enzyme's broad 17beta-HSD activity across several
      17-oxosteroid substrates (androstenedione, DHEA, androstanedione, 11-oxygenated
      C19 steroids), reducing them at C-17 using NADPH. Complements the more specific
      testosterone dehydrogenase term.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "Favors the reduction of"
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:28514442
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding annotation from a high-throughput affinity-purification
      mass-spectrometry human interactome map (BioPlex), with interactor NCS1
      (UniProtKB:P62166).
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Bare "protein binding" from a proteome-scale interactome screen is
      uninformative about the molecular function of HSD17B3 and does not represent
      a characterized, biologically interpreted interaction. Per curation guidelines,
      such generic protein-binding terms should not be treated as core function.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "P37058; P62166: NCS1;"
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding annotation from a second proteome-scale AP-MS human
      interactome study (BioPlex 3.0), again with interactor NCS1 (UniProtKB:P62166).
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      As with the companion interactome dataset, this generic "protein binding"
      annotation from a high-throughput screen is uninformative for molecular
      function and is not core.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "P37058; P62166: NCS1;"
- term:
    id: GO:0006702
    label: androgen biosynthetic process
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-193048
  qualifier: involved_in
  review:
    summary: >-
      TAS (Reactome, Androgen biosynthesis) assignment to androgen biosynthetic
      process. HSD17B3 catalyses the terminal androstenedione->testosterone step
      of androgen (testosterone) biosynthesis.
    action: ACCEPT
    reason: >-
      Testosterone is an androgen and HSD17B3 performs the final reductive step of
      its synthesis, so this is a correct and central biological-process annotation.
    supported_by:
    - reference_id: PMID:8075637
      supporting_text: "Defects in the conversion of androstenedione to testosterone in the fetal testes"
- term:
    id: GO:0061370
    label: testosterone biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000041
  qualifier: involved_in
  review:
    summary: >-
      IEA (UniPathway UPA00367) assignment to testosterone biosynthetic process,
      the most specific biological process for this enzyme's role.
    action: ACCEPT
    reason: >-
      HSD17B3 catalyses the final, committed step producing testosterone; UniProt
      records the pathway "Hormone biosynthesis; testosterone biosynthesis". This is
      the most precise BP term and represents a core function.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "Hormone biosynthesis; testosterone biosynthesis."
- term:
    id: GO:0047045
    label: testosterone dehydrogenase (NADP+) activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-193064
  qualifier: enables
  review:
    summary: >-
      TAS (Reactome, HSD17B3-like proteins reduce ANDST to TEST) assignment of
      testosterone dehydrogenase (NADP+) activity, duplicating the core molecular
      function.
    action: ACCEPT
    reason: >-
      Core catalytic function; consistent with the IBA/IDA/IEA annotations of the
      same term and with the reduction of androstenedione to testosterone.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "testosterone + NADP(+) = androst-4-ene-3,17-dione + NADPH"
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: IDA
  original_reference_id: PMID:26545797
  qualifier: located_in
  review:
    summary: >-
      IDA localization to the endoplasmic reticulum. Engeli et al. expressed
      wild-type 17beta-HSD3 (and the G133R mutant) in HEK-293 cells and assessed
      intracellular localization; both showed comparable ER localization.
    action: ACCEPT
    reason: >-
      Direct experimental evidence for ER localization of the human enzyme in a
      cellular expression system, consistent with its membrane anchor.
    supported_by:
    - reference_id: PMID:26545797
      supporting_text: "showed comparable expression levels and intracellular localization."
- term:
    id: GO:0047045
    label: testosterone dehydrogenase (NADP+) activity
  evidence_type: IDA
  original_reference_id: PMID:26545797
  qualifier: enables
  review:
    summary: >-
      IDA for testosterone dehydrogenase (NADP+) activity. Engeli et al. measured
      the conversion of androstenedione to testosterone by wild-type 17beta-HSD3
      (nearly abolished in the disease mutant G133R), directly demonstrating the
      enzyme activity.
    action: ACCEPT
    reason: >-
      Direct assay of the enzyme's testosterone-producing 17beta-reductase activity
      in a human expression system; the defining core molecular function.
    supported_by:
    - reference_id: PMID:26545797
      supporting_text: "conversion of Δ4-androstene-3,17-dione (androstenedione) to testosterone was"
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-193064
  qualifier: located_in
  review:
    summary: >-
      TAS (Reactome) localization to the endoplasmic reticulum membrane, the most
      precise cellular-component term. HSD17B3 has an N-terminal hydrophobic segment
      that anchors it in the ER membrane.
    action: ACCEPT
    reason: >-
      Most specific and accurate location for this membrane-anchored ER enzyme;
      preferred over the parent GO:0005783 term.
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Endoplasmic reticulum"
- term:
    id: GO:0030539
    label: male genitalia development
  evidence_type: TAS
  original_reference_id: PMID:8075637
  qualifier: involved_in
  review:
    summary: >-
      TAS (Geissler et al. 1994) involvement in male genitalia development.
      Deficiency of 17beta-HSD3 impairs fetal testicular testosterone synthesis,
      giving 46,XY individuals female external genitalia (male pseudohermaphroditism).
    action: KEEP_AS_NON_CORE
    reason: >-
      This is a real but downstream physiological/developmental consequence of the
      enzyme's biochemical activity (testosterone drives male sexual differentiation),
      not the molecular/biosynthetic core function. Retained as non-core to preserve
      the well-established disease/developmental link.
    supported_by:
    - reference_id: PMID:8075637
      supporting_text: "Defects in the conversion of androstenedione to testosterone in the fetal testes"
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "inadequate testicular synthesis of"
- term:
    id: GO:0043231
    label: intracellular membrane-bounded organelle
  evidence_type: TAS
  original_reference_id: PMID:8075637
  qualifier: located_in
  review:
    summary: >-
      TAS (Geissler et al. 1994) localization to an intracellular membrane-bounded
      organelle. The original paper described the enzyme as microsomal (ER); the
      annotation is correct but far more general than the known ER localization.
    action: MODIFY
    reason: >-
      The enzyme is specifically an ER (microsomal) membrane protein, established by
      direct experimental evidence. This generic organelle term should be replaced
      with the specific endoplasmic reticulum term.
    proposed_replacement_terms:
    - id: GO:0005783
      label: endoplasmic reticulum
    supported_by:
    - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Endoplasmic reticulum"
core_functions:
- description: >-
    NADPH-dependent 17beta-hydroxysteroid (testosterone) dehydrogenase that
    catalyses the final step of testosterone biosynthesis in the testis, reducing
    the 17-keto group of androstenedione to give testosterone at the endoplasmic
    reticulum membrane.
  molecular_function:
    id: GO:0047045
    label: testosterone dehydrogenase (NADP+) activity
  directly_involved_in:
  - id: GO:0006702
    label: androgen biosynthetic process
  - id: GO:0061370
    label: testosterone biosynthetic process
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  supported_by:
  - reference_id: file:human/HSD17B3/HSD17B3-uniprot.txt
    supporting_text: "testosterone + NADP(+) = androst-4-ene-3,17-dione + NADPH"
  - reference_id: PMID:26545797
    supporting_text: "conversion of Δ4-androstene-3,17-dione (androstenedione) to testosterone was"
references:
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000041
  title: Gene Ontology annotation based on UniPathway vocabulary mapping
  findings: []
- id: GO_REF:0000116
  title: Automatic Gene Ontology annotation based on Rhea mapping
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: file:human/HSD17B3/HSD17B3-uniprot.txt
  title: UniProtKB entry P37058 (DHB3_HUMAN), 17-beta-hydroxysteroid dehydrogenase type 3
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Curated UniProt record; source for catalytic activity (RHEA:14981/EC 1.1.1.64
      testosterone/androstenedione; RHEA:24616/EC 1.1.1.62 estradiol/estrone),
      NADPH cofactor use, ER subcellular location, testis tissue specificity, and
      the 46,XY DSD disease association.
- id: PMID:26545797
  title: Biochemical analyses and molecular modeling explain the functional loss of
    17β-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with
    46, XY Disorders of Sex Development.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Abstract-only in cache. Directly measures wild-type 17beta-HSD3 androstenedione->
      testosterone conversion and ER localization in HEK-293 cells; basis for the IDA
      MF and ER-localization annotations.
- id: PMID:28514442
  title: Architecture of the human interactome defines protein communities and disease
    networks.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput AP-MS interactome (BioPlex). Source of a generic IPI
      protein-binding annotation (interactor NCS1/P62166); uninformative for
      molecular function.
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput AP-MS interactome (BioPlex 3.0). Source of a second generic
      IPI protein-binding annotation (interactor NCS1/P62166); uninformative for
      molecular function.
- id: PMID:8075637
  title: Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid
    dehydrogenase 3.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Abstract-only in cache. Landmark paper identifying HSD17B3, its testis-predominant
      expression, NADPH cofactor use, and disease-causing mutations; basis for the MF,
      testis tissue, disease, and male-genitalia-development annotations.
- id: Reactome:R-HSA-193048
  title: Androgen biosynthesis
  findings: []
- id: Reactome:R-HSA-193064
  title: HSD17B3-like proteins reducde ANDST to TEST
  findings: []